Scholarlink

<p><b>Objective.</b> To evaluate objective and subjective sleep parameters in patients with chronic tension-type headache and their dynamics during therapy. <b>Materials and methods.</b> The study involved 65 patients with chronic tension-type headache and insomnia. Assessments were conducted using headache questionnaires (headache VAS, headache diary, HIT-6, pain catastrophizing scale), sleep quality questionnaires (Pittsburgh Sleep Quality Questionnaire (PSQI), sleep quality VAS), psychometric testing (Beck Depression Inventory, Sheehan Anxiety Inventory), and a central sensitization questionnaire, along with polysomnography. Patients were divided into two groups: patients of group 1 received preventive treatment in accordance with clinical guidelines, a drug for the relief of insomnia symptoms, and recommendations for sleep hygiene, while patients of group 2 received only a drug to prevent headaches. <b>Results.</b> In the group with insomnia correction, the duration of the S3 phase of slow-wave sleep increased from 31.5 (27; 36) to 47 (42; 49) min) and subjective sleep duration increased from 360 ± 90 to 453.33 ± 66.14 min, while the severity of insomnia on the PSQI decreased from 13 (10; 15) to 7 (5; 10) points), headache frequency decreased from 20.00 [17.00; 24.00] to 8.00 [5.00; 11.00] days, pain intensity on the VAS decreased from 7.00 [6.00; 7.00] to 4.00 [3.00; 6.00] points, the severity of anxiety on the Sheehan Anxiety Scale decreased from 43 [26; 51] to 19 [16;34 ] points, and the severity of depression on the Beck Depression Inventory decreased from 14 [12; 18] to 7 [6; 10.5] points. <b>Conclusion.</b> Identification and treatment of insomnia in patients with chronic tension-type headache is an important strategy in the management of this group of patients, providing a route not only to improving objective and subjective sleep parameters, but also to reducing the manifestations of headache and the severity of comorbidity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of Insomnia Therapy on Treatment Outcomes in Patients with Chronic Tension Headache

  • 期刊论文

  • 发表日期：

    2025年11月1日

查看全文
  • V. D. Tkachenko,
  • E. A. Korabelnikova

摘要

Objective. To evaluate objective and subjective sleep parameters in patients with chronic tension-type headache and their dynamics during therapy. Materials and methods. The study involved 65 patients with chronic tension-type headache and insomnia. Assessments were conducted using headache questionnaires (headache VAS, headache diary, HIT-6, pain catastrophizing scale), sleep quality questionnaires (Pittsburgh Sleep Quality Questionnaire (PSQI), sleep quality VAS), psychometric testing (Beck Depression Inventory, Sheehan Anxiety Inventory), and a central sensitization questionnaire, along with polysomnography. Patients were divided into two groups: patients of group 1 received preventive treatment in accordance with clinical guidelines, a drug for the relief of insomnia symptoms, and recommendations for sleep hygiene, while patients of group 2 received only a drug to prevent headaches. Results. In the group with insomnia correction, the duration of the S3 phase of slow-wave sleep increased from 31.5 (27; 36) to 47 (42; 49) min) and subjective sleep duration increased from 360 ± 90 to 453.33 ± 66.14 min, while the severity of insomnia on the PSQI decreased from 13 (10; 15) to 7 (5; 10) points), headache frequency decreased from 20.00 [17.00; 24.00] to 8.00 [5.00; 11.00] days, pain intensity on the VAS decreased from 7.00 [6.00; 7.00] to 4.00 [3.00; 6.00] points, the severity of anxiety on the Sheehan Anxiety Scale decreased from 43 [26; 51] to 19 [16;34 ] points, and the severity of depression on the Beck Depression Inventory decreased from 14 [12; 18] to 7 [6; 10.5] points. Conclusion. Identification and treatment of insomnia in patients with chronic tension-type headache is an important strategy in the management of this group of patients, providing a route not only to improving objective and subjective sleep parameters, but also to reducing the manifestations of headache and the severity of comorbidity.